Provided by Tiger Fintech (Singapore) Pte. Ltd.

Baxter

36.57
+1.133.19%
Pre-market: 36.27-0.3000-0.82%08:38 EDT
Volume:4.55M
Turnover:164.92M
Market Cap:18.71B
PE:-28.74
High:36.64
Open:35.34
Low:35.06
Close:35.44
Loading ...

Company Profile

Company Name:
Baxter
Exchange:
NYSE
Establishment Date:
1931
Employees:
38000
Office Location:
One Baxter Parkway,Deerfield,Illinois,United States
Zip Code:
60015
Fax:
- -
Introduction:
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Directors

Name
Position
Brent Shafer
Interim CEO and Chair
Cathy R. Smith
Independent Director
David S. Wilkes
Independent Director
Nancy M. Schlichting
Lead Independent Director
Patricia B. Morrison
Independent Director
Stephen H. Rusckowski
Independent Director
Stephen N. Oesterle
Independent Director
William Ampofo II
Independent Director
Amy A. Wendell
Director
Jeffrey A. Craig
Director

Shareholders

Name
Position
Anita Zielinski
Senior Vice President, Chief Accounting Officer and Controller
Joel T. Grade
Executive Vice President and Chief Financial Officer
Alok Sonig
Executive Vice President and Group President, Pharmaceuticals
Brent Shafer
Interim CEO and Chair
David S. Rosenbloom
Executive Vice President and General Counsel
Heather Knight
Executive Vice President and Group President, Medical Products and Therapies
James Borzi
Executive Vice President and Chief Supply Chain Officer
Jeanne K. Mason
Executive Vice President and Chief Human Resources Officer
Reazur Rasul
Executive Vice President and Group President, Healthcare Systems and Technologies